Conduent Launches Digital Solution to Help Pharmas with Faster and More Effective Product Commercialization
January 12 2023 - 8:45AM
Conduent Incorporated (Nasdaq: CNDT), a global technology-led
business process solutions company, today announced the launch of
the IntelliHealth module for healthcare provider engagement. This
new module is an end-to-end solution to help pharma organizations
improve access to, and increase engagement with, healthcare
professionals to drive focused pharmaceutical sales and marketing.
IntelliHealth enables pharma organizations to power faster and more
effective product commercialization with advanced analytics,
omnichannel communication and experienced sales professionals and
medical science liaisons. The robust platform delivers highly
flexible hybrid engagement models that enable pharma organizations
to reduce risk, manage costs and gain competitive advantages while
driving ROI across the full life cycle of a drug therapy.
Pharma organizations are quickly adapting to the new normal
where face-to-face contact to educate healthcare providers (HCPs)
on established and emerging drug therapies has given way to remote
interactions. The HCP now dictates when interactions occur across a
variety of communications channels. IntelliHealth is built on
state-of-the-art modular architecture and application programming
interfaces that integrate with other third-party services to drive
omnichannel engagement from drug launch to maturity with measurable
outcomes across the product lifecycle. The next-generation
technology is matched with the company’s proven experience in
delivering emergent campaigns, via remote and digital engagement,
to create a seamless experience for HCPs.
“Physicians and clinicians now determine when and how they
engage, and new brands are quickly coming to market to increase
competition across multiple therapy classes. Our pharma clients
require HCP engagement models that advance their brands in a
fast-changing and complex landscape,” said Randall King, President,
Commercial Solutions at Conduent. “Hybrid commercialization models
are now essential and the IntelliHealth module for healthcare
provider engagement offers pharma leaders a complete,
technology-enabled solution to customize, scale and execute their
go-to-market strategies with enough agility to sustain long-term
brand awareness.”
Conduent has helped pharma organizations launch and maintain
brands for more than 30 years. The company serves seven of the 10
largest pharma and life sciences organizations with focused
solutions including patient access services, hub programs, global
medical information and sales and marketing services that span the
product life cycle. Learn more at
https://www.conduent.com/industry/healthcare/pharmaceuticals-and-life-sciences/.
About ConduentConduent delivers
mission-critical services and solutions on behalf of businesses and
governments – creating exceptional outcomes for its clients and the
millions of people who count on them. Through our dedicated people,
processes, and technologies, Conduent solutions and services
enhance customer experience, increase efficiencies, reduce costs,
and improve performance for most Fortune 100 companies and more
than 500 government entities. Whether it’s touching three out of
every four health insured lives and delivering 45% of SNAP payments
in the U.S., or enabling 1.3 billion customer service interactions
and empowering 10 million employees through HR services worldwide,
Conduent services and solutions interact with millions of people
every day and move our clients’ operations forward. Learn more at
https://www.conduent.com.
Media Contact:Sharon Lakes, Conduent,
+1-469-750-5403, sharon.lakes2@conduent.com
Investor Relations Contact:Giles Goodburn,
Conduent, +1-203-216-3546, ir@conduent.com
Note: To receive RSS news feeds, visit
www.news.conduent.com. For open commentary, industry perspectives,
and views, visit http://twitter.com/Conduent,
http://www.linkedin.com/company/conduent or
http://www.facebook.com/Conduenthttp://www.facebook.com/Conduent.
TrademarksConduent is a trademark of Conduent
Incorporated in the United States and/or other countries. Other
names may be trademarks of their respective owners.
Conduent (NASDAQ:CNDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conduent (NASDAQ:CNDT)
Historical Stock Chart
From Apr 2023 to Apr 2024